LEPTIN - ANVISA Registration 80564740021

Access comprehensive regulatory information for LEPTIN in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80564740021 and manufactured by DIASOURCE IMMUNOASSAYS S.A. The registration is held by CECON CENTRO DE CONTRÔLE E PRODUTOS PARA DIAGNÓSTICOS LTDA. with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including DRG INTERNATIONAL, INC., DRG INSTRUMENTS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.